Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Blum

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Blood|June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2007
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cellsShujun Liu, Rebecca B Klisovic, Tamara Vukosavljevic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantationMehdi Hamadani, Craig C Hofmeister, Buffy Jansak, et al.
Leukemia & Lymphoma|January 20, 2016
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemiaAlison R Walker, Hongyan Wang, Katherine Walsh, et al.
Blood|October 31, 2002
Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantationRavi Vij, John F DiPersio, Partha Venkatraman, et al.
IEEE International Workshop on Genomic Signal Processing and Statistics : [Proceedings]. IEEE International Workshop on Genomic Signal Processing and Statistics|April 10, 2012
A Scalable, Flexible Workflow for MethylCap-Seq Data AnalysisBenjamin Rodriguez, Hok-Hei Tam, David Frankhouser, et al.
Leukemia & Lymphoma|September 11, 2013
Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemiaRebecca B Klisovic, William Blum, Zhongfa Liu, et al.
Blood|May 6, 2004
Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamideMark Girgis, Chris Hallemeier, William Blum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the NucleusParvathi Ranganathan, Trinayan Kashyap, Xueyan Yu, et al.
Leukemia & Lymphoma|February 11, 2020
Phase I study of AR-42 and decitabine in acute myeloid leukemiaSophia G Liva, Christopher C Coss, Jiang Wang, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Blood|June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2007
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cellsShujun Liu, Rebecca B Klisovic, Tamara Vukosavljevic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantationMehdi Hamadani, Craig C Hofmeister, Buffy Jansak, et al.
Leukemia & Lymphoma|January 20, 2016
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemiaAlison R Walker, Hongyan Wang, Katherine Walsh, et al.
Blood|October 31, 2002
Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantationRavi Vij, John F DiPersio, Partha Venkatraman, et al.
IEEE International Workshop on Genomic Signal Processing and Statistics : [Proceedings]. IEEE International Workshop on Genomic Signal Processing and Statistics|April 10, 2012
A Scalable, Flexible Workflow for MethylCap-Seq Data AnalysisBenjamin Rodriguez, Hok-Hei Tam, David Frankhouser, et al.
Leukemia & Lymphoma|September 11, 2013
Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemiaRebecca B Klisovic, William Blum, Zhongfa Liu, et al.
Blood|May 6, 2004
Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamideMark Girgis, Chris Hallemeier, William Blum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the NucleusParvathi Ranganathan, Trinayan Kashyap, Xueyan Yu, et al.
Leukemia & Lymphoma|February 11, 2020
Phase I study of AR-42 and decitabine in acute myeloid leukemiaSophia G Liva, Christopher C Coss, Jiang Wang, et al.
Pageof 12